Client was one of the leader in generics and biopharmaceuticals seeking to develop patient journey for prophylaxis and acute migraine patients in USA, Korea, Turkey, China and Russia
Methodology
A collaborative effort including primary and secondary research was conducted:
Primary research:
~60 mins qualitative (n=15, 5 per country) interviews with HCPs (neurologists and headache specialists) was conducted to gather information for various level of patient journey including pre-diagnosis, diagnosis, 1st line treatment, 2nd line treatment, 3rd line treatment, and maintenance treatment
~40 mins quantitative interview with HCPs, patients, and payers to understand number of patient with acute and prophylaxis migraine, diagnosis rate, treatment rate, etc.
Secondary research:
A thorough research on several topics including patient unmet needs, country demographics, HCP perception, and patient archetypes was conducted
Outcome
A full fledged PPT deck was presented per country along with recommendation